DEF 14A

Company

X4 Pharmaceuticals, Inc

Filed

April 23, 2018

Period of Report

June 5, 2018

Accession Number

0001193125-18-125788

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →